Article
LYRM2 Promotes the Growth and Metastasis of Hepatocellular Carcinoma via Enhancing HIF ‐1α‐Dependent Glucose Metabolic Reprogramming
1 Dec 2024
Abstract excerpt
Hepatocellular carcinoma (HCC) is a foetal malignancy with dismal overall survival. The molecular mechanism underlying the progression of HCC remain largely unknown. LYR motif containing 2 (LYRM2) has been identified as an oncogene in colorectal cancer; however, its expression, functions and molecular mechanism in the context of HCC has not been investigated. Data derived from The Cancer Gemome Atlas, along with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
